Jinmei Liu

847 total citations
21 papers, 365 citations indexed

About

Jinmei Liu is a scholar working on Pediatrics, Perinatology and Child Health, Anesthesiology and Pain Medicine and Molecular Biology. According to data from OpenAlex, Jinmei Liu has authored 21 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 5 papers in Anesthesiology and Pain Medicine and 4 papers in Molecular Biology. Recurrent topics in Jinmei Liu's work include Pain Management and Opioid Use (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Advanced Sensor and Energy Harvesting Materials (3 papers). Jinmei Liu is often cited by papers focused on Pain Management and Opioid Use (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Advanced Sensor and Energy Harvesting Materials (3 papers). Jinmei Liu collaborates with scholars based in China, United States and Switzerland. Jinmei Liu's co-authors include Yong Qin, Yong‐Wei Zhang, Qi Xu, Sining Yun, Zhiwen Fu, Yongning Lu, Xuejia Zhai, Jianguo Chen, Yu Zhang and Shijun Li and has published in prestigious journals such as Nano Energy, Nanotechnology and Food and Chemical Toxicology.

In The Last Decade

Jinmei Liu

19 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinmei Liu China 8 135 83 73 57 52 21 365
Jiexue Wang China 10 75 0.6× 32 0.4× 29 0.4× 57 1.0× 36 0.7× 24 296
Shiyu Wang China 12 220 1.6× 168 2.0× 116 1.6× 100 1.8× 22 0.4× 73 476
Shan Gao China 13 54 0.4× 28 0.3× 25 0.3× 255 4.5× 112 2.2× 62 570
Wenxiu Xu China 11 114 0.8× 105 1.3× 53 0.7× 81 1.4× 129 2.5× 33 468
Jingjing Wen China 9 125 0.9× 36 0.4× 105 1.4× 109 1.9× 42 0.8× 26 375
Ara Kim South Korea 9 62 0.5× 86 1.0× 32 0.4× 257 4.5× 51 1.0× 27 494
Pei‐Wen Huang China 11 113 0.8× 89 1.1× 43 0.6× 93 1.6× 52 1.0× 44 438
Ammaiyappan Bharathi Sankar India 9 212 1.6× 55 0.7× 284 3.9× 78 1.4× 82 1.6× 18 449
Xuanzhao Lu China 12 138 1.0× 100 1.2× 58 0.8× 122 2.1× 74 1.4× 28 420

Countries citing papers authored by Jinmei Liu

Since Specialization
Citations

This map shows the geographic impact of Jinmei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinmei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinmei Liu more than expected).

Fields of papers citing papers by Jinmei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinmei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinmei Liu. The network helps show where Jinmei Liu may publish in the future.

Co-authorship network of co-authors of Jinmei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinmei Liu. A scholar is included among the top collaborators of Jinmei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinmei Liu. Jinmei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuan, Ya Zhang, Jinmei Liu, et al.. (2025). Analysis of TORCH screening and prenatal risk assessment for childbearing-age women in different regions of China. Journal of Health Population and Nutrition. 44(1). 331–331.
2.
Zhang, Cong, et al.. (2025). Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysis. Frontiers in Pharmacology. 16. 1598972–1598972. 1 indexed citations
3.
Liu, Jinmei, Juan Luo, Xu Chen, et al.. (2024). Opioid Nonadherence Risk Prediction of Patients with Cancer‐Related Pain Based on Five Machine Learning Algorithms. Pain Research and Management. 2024(1). 7347876–7347876. 1 indexed citations
4.
Fu, Zhiwen, Jinmei Liu, Cong Zhang, et al.. (2024). Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database. Frontiers in Pharmacology. 15. 1383212–1383212. 2 indexed citations
5.
6.
Wang, Weiwei, Xiaozhou Lü, Yunchao Wang, et al.. (2024). Mitigating public hygiene anxiety in waste material applications: Development of an antibacterial and high performance triboelectric nanogenerator from recycled PET. Nano Energy. 134. 110533–110533. 7 indexed citations
7.
Hu, Huiping, Zhiwen Fu, Jinmei Liu, et al.. (2024). Pulmonary haemorrhage and haemoptysis associated with bevacizumab-related treatment regimens: a retrospective, pharmacovigilance study using the FAERS database. Frontiers in Pharmacology. 15. 1339505–1339505. 3 indexed citations
8.
Wang, Cong, Zhiwen Fu, Jinmei Liu, et al.. (2024). Lipocalin 2 (LCN2) confers acquired resistance to almonertinib in NSCLC through LCN2-MMP-9 signaling pathway. Pharmacological Research. 201. 107088–107088. 7 indexed citations
9.
Zhao, Jiajia, et al.. (2024). The regulation and its application of the charge decay rate in triboelectric nanogenerator. Nanotechnology. 35(33). 335402–335402. 2 indexed citations
10.
Shi, Chen, Cong Zhang, Zhiwen Fu, et al.. (2023). Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations. Acta Pharmaceutica Sinica B. 13(6). 2613–2627. 6 indexed citations
11.
12.
Shi, Chen, Jinmei Liu, Jianli Hu, et al.. (2022). Genetic and Clinical Factors Associated with Opioid Response in Chinese Han Patients with Cancer Pain: An Exploratory Cross-Sectional Study. Pain and Therapy. 11(1). 269–288. 4 indexed citations
13.
Fu, Zhiwen, Shijun Li, Jinmei Liu, et al.. (2022). Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer. Frontiers in Pharmacology. 13. 18 indexed citations
14.
Liu, Jinmei, Ming Zhang, Juan Luo, et al.. (2021). Practice, Knowledge, and Attitude of Health Care Providers regarding Cancer Pain Management: A National Survey. Pain Research and Management. 2021. 1–12. 7 indexed citations
15.
Chen, Shi, Xiong Wang, Jinmei Liu, et al.. (2021). Toxicities and Associated Factors in Patients Receiving Temozolomide-Containing Regimens: A 12-Year Analysis of Hospital Data. Drug Design Development and Therapy. Volume 15. 2151–2159. 5 indexed citations
16.
17.
Han, Chong, Qiang Li, Jinmei Liu, et al.. (2019). Characterization, evolution, and expression analysis of TLR7 gene subfamily members in Mastacembelus armatus (Synbranchiformes: Mastacembelidae). Developmental & Comparative Immunology. 95. 77–88. 15 indexed citations
18.
Yun, Sining, Yong‐Wei Zhang, Qi Xu, Jinmei Liu, & Yong Qin. (2019). Recent advance in new-generation integrated devices for energy harvesting and storage. Nano Energy. 60. 600–619. 215 indexed citations
19.
Liu, Yani, et al.. (2012). A simple and sensitive liquid chromatographic technique for the determination of cefotetan disodium in human plasma and its application in a pharmacokinetic study. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(5). 779–784. 4 indexed citations
20.
Zhai, Xuejia, et al.. (2012). Food–drug interactions: Effect of capsaicin on the pharmacokinetics of simvastatin and its active metabolite in rats. Food and Chemical Toxicology. 53. 168–173. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiexue Wang Breakdown of academic impact, for papers by Shiyu Wang Breakdown of academic impact, for papers by Shan Gao Breakdown of academic impact, for papers by Wenxiu Xu Breakdown of academic impact, for papers by Jingjing Wen Breakdown of academic impact, for papers by Ara Kim Breakdown of academic impact, for papers by Pei‐Wen Huang Breakdown of academic impact, for papers by Ammaiyappan Bharathi Sankar Breakdown of academic impact, for papers by Xuanzhao Lu
Rankless by CCL
2026